Great Valley Advisor Group’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.06M | Buy |
47,166
+1,398
| +3% | +$164K | 0.1% | 191 |
|
|
2026
Q1 | $5.51M | Buy |
45,768
+579
| +1% | +$66.8K | 0.1% | 181 |
|
|
2025
Q4 | $4.76M | Sell |
45,189
-1,828
| -4% | -$172K | 0.09% | 199 |
|
|
2025
Q3 | $3.95M | Sell |
47,017
-51,947
| -52% | -$4.28M | 0.08% | 214 |
|
|
2025
Q2 | $7.83M | Sell |
98,964
-5,160
| -5% | -$410K | 0.17% | 129 |
|
|
2025
Q1 | $9.35M | Sell |
104,124
-4,651
| -4% | -$434K | 0.2% | 119 |
|
|
2024
Q4 | $10.8M | Buy |
108,775
+6,112
| +6% | +$630K | 0.24% | 100 |
|
|
2024
Q3 | $11.7M | Buy |
102,663
+7,064
| +7% | +$839K | 0.29% | 90 |
|
|
2024
Q2 | $11.8M | Buy |
95,599
+5,885
| +7% | +$758K | 0.33% | 80 |
|
|
2024
Q1 | $11.8M | Sell |
89,714
-9,337
| -9% | -$1.15M | 0.36% | 71 |
|
|
2023
Q4 | $10.8M | Buy |
99,051
+5,982
| +6% | +$621K | 0.38% | 66 |
|
|
2023
Q3 | $9.58M | Buy |
93,069
+9,052
| +11% | +$976K | 0.4% | 67 |
|
|
2023
Q2 | $9.69M | Buy |
84,017
+2,499
| +3% | +$284K | 0.41% | 63 |
|
|
2023
Q1 | $8.67M | Buy |
81,518
+5,292
| +7% | +$571K | 0.4% | 64 |
|
|
2022
Q4 | $8.46M | Buy |
76,226
+24,931
| +49% | +$2.55M | 0.43% | 56 |
|
|
2022
Q3 | $4.42M | Sell |
51,295
-1,372
| -3% | -$122K | 0.25% | 101 |
|
|
2022
Q2 | $4.8M | Buy |
52,667
+6,745
| +15% | +$598K | 0.26% | 94 |
|
|
2022
Q1 | $3.64M | Sell |
45,922
-476
| -1% | -$37.5K | 0.21% | 123 |
|
|
2021
Q4 | $3.52M | Sell |
46,398
-293
| -0.6% | -$23.3K | 0.22% | 119 |
|
|
2021
Q3 | $3.51M | Sell |
46,691
-1,293
| -3% | -$98.3K | 0.24% | 113 |
|
|
2021
Q2 | $3.72M | Sell |
47,984
-2,631
| -5% | -$196K | 0.27% | 98 |
|
|
2021
Q1 | $3.72M | Sell |
50,615
-8,921
| -15% | -$658K | 0.36% | 62 |
|
|
2020
Q4 | $4.65M | Buy |
59,536
+2,956
| +5% | +$226K | 0.48% | 44 |
|
|
2020
Q3 | $4.48M | Sell |
56,580
-1,492
| -3% | -$117K | 0.55% | 39 |
|
|
2020
Q2 | $4.29M | Buy |
58,072
+11,149
| +24% | +$839K | 0.7% | 31 |
|
|
2020
Q1 | $3.44M | Buy |
46,923
+4,284
| +10% | +$337K | 0.91% | 24 |
|
|
2019
Q4 | $3.7M | Sell |
42,639
-2,354
| -5% | -$193K | 0.82% | 23 |
|
|
2019
Q3 | $3.61M | Buy |
44,993
+516
| +1% | +$41.4K | 0.87% | 19 |
|
|
2019
Q2 | $3.55M | Buy |
44,477
+18,937
| +74% | +$1.45M | 0.89% | 19 |
|
|
2019
Q1 | $2.03M | Buy |
25,540
+6,483
| +34% | +$485K | 0.64% | 36 |
|
|
2018
Q4 | $1.39M | Buy |
+19,057
| New | +$1.35M | 0.52% | 48 |
|
Other funds holding MRK
Great Valley Advisor Group's MRK Position: Q2 2026 in Review
Great Valley Advisor Group increased its Merck (MRK) stake by 3.1% in Q2 2026, buying an estimated $164K and bringing the position to 47,166 shares worth $6.06M. The position accounts for 0.1% of the portfolio, ranked #191.
Great Valley Advisor Group first reported a position in MRK in Q4 2018 and has held it in 31 quarters since. The position peaked at $11.8M in Q1 2024. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Great Valley Advisor Group held 47,166 shares of Merck worth $6.06M as of Q2 2026.
- Great Valley Advisor Group bought 1,398 Merck shares in Q2 2026, an estimated $164K.
- Merck made up 0.1% of Great Valley Advisor Group's portfolio in Q2 2026, its #191 holding.
- Great Valley Advisor Group first reported a position in Merck in Q4 2018 and has held it in 31 quarters since.
- Great Valley Advisor Group's Merck position peaked at $11.8M in Q1 2024.
- 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Great Valley Advisor Group's 13F filing for Q2 2026, filed 10 Aug 2026.